New UK Market Surveillance Fee Could Cost Medtech Millions Each Year
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency wants to charge an annual fee to medical device manufacturers for its market surveillance activities that could cost industry as a whole around £9m ($13.6m).